ZA867747B - Stabilization of interferons - Google Patents

Stabilization of interferons

Info

Publication number
ZA867747B
ZA867747B ZA867747A ZA867747A ZA867747B ZA 867747 B ZA867747 B ZA 867747B ZA 867747 A ZA867747 A ZA 867747A ZA 867747 A ZA867747 A ZA 867747A ZA 867747 B ZA867747 B ZA 867747B
Authority
ZA
South Africa
Prior art keywords
mmol
stabilization
interferons
polyphosphate
guarantees
Prior art date
Application number
ZA867747A
Inventor
Harald Gallati
Inge Pracht
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA867747B publication Critical patent/ZA867747B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/217IFN-gamma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE A composition containing interferon, a phosphate buffer system, which guarantees a pH value of 6.0-9.0, preferably of 7.5, and which has a phosphate concentration of 500-1000 mmol/l, preferably 1000 mmol/l, and/or polyphosphate. 1. Claims for the Contracting State : AT The use of a phosphate buffer system, which guarantees a pH value of 6.0-9.0, preferably of 7.5, and which has a phosphate concentration of 500-1000 mmol/l, preferably 1000 mmol/l, or of polyphosphate for the stabilization of interferon.
ZA867747A 1985-10-15 1986-10-13 Stabilization of interferons ZA867747B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH443385 1985-10-15

Publications (1)

Publication Number Publication Date
ZA867747B true ZA867747B (en) 1988-02-24

Family

ID=4276045

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA867747A ZA867747B (en) 1985-10-15 1986-10-13 Stabilization of interferons

Country Status (10)

Country Link
EP (1) EP0219073B1 (en)
JP (1) JPS6293300A (en)
AT (1) ATE50694T1 (en)
AU (1) AU591525B2 (en)
DE (1) DE3669263D1 (en)
DK (1) DK163280C (en)
IL (1) IL80288A0 (en)
NZ (1) NZ217885A (en)
PH (1) PH22805A (en)
ZA (1) ZA867747B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5318685A (en) * 1987-08-18 1994-06-07 Cardinal Ig Company Method of making metal oxide films having barrier properties
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
FR2654343B1 (en) * 1989-11-10 1994-08-05 Roussel Uclaf USE OF A POLYPEPTIDE HAVING THE ACTIVITY OF INTERFERON GAMMA FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PRIMITIVE CANCERS OF THE FLEAVE.
JPH0771459B2 (en) * 1991-05-15 1995-08-02 三協食品工業株式会社 Functional food material and manufacturing method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA828580B (en) * 1981-12-23 1983-10-26 Schering Corp Interferon formulations
JPS6034919A (en) * 1983-08-04 1985-02-22 Green Cross Corp:The Gamma interferon composition
JPS61221129A (en) * 1985-03-25 1986-10-01 シエリング・コーポレーシヨン Stable gamma-interferon medicine

Also Published As

Publication number Publication date
ATE50694T1 (en) 1990-03-15
NZ217885A (en) 1989-06-28
DK488586D0 (en) 1986-10-13
AU6387286A (en) 1987-04-16
EP0219073A2 (en) 1987-04-22
EP0219073B1 (en) 1990-03-07
DK163280C (en) 1992-07-06
JPS6293300A (en) 1987-04-28
DE3669263D1 (en) 1990-04-12
AU591525B2 (en) 1989-12-07
EP0219073A3 (en) 1987-09-23
DK163280B (en) 1992-02-17
PH22805A (en) 1988-12-27
IL80288A0 (en) 1987-01-30
DK488586A (en) 1987-04-16

Similar Documents

Publication Publication Date Title
DE3564157D1 (en) Equipment for the determination of the activity or concentration of ions in solutions
EP0206810A3 (en) Acrylate compound and composition containing the same
EP0207158A4 (en) Anti-asthmatic composition containing 8,11,14,17-eicosatetraenoic acid.
IL76182A0 (en) Stabilization of elastomers with aliphatic-phenyldiamines and aliphatic phosphite compounds
EP0222485A3 (en) Condensing furnace with corrosion suppression
ZA868155B (en) Stabilization of iron in aqueous systems
IL79699A0 (en) Antiviral compositions containing 2',3'-dideoxycytidine or its mono-or triphosphate
PH22805A (en) Stabilization of interferons
GR77719B (en)
EP0340391A3 (en) 1,4-disubstituted-2,3,4,6-tetrahydroxy-1,4-diphosphorinane and their oxides or sulfides
EP0197793A3 (en) Stabilizing polyolefins
EP0208275A3 (en) Arrangement for the bitparallel addition of binary numbers
EP0227104A3 (en) Particles containing iron carbide
GB2173821B (en) Improvements in or relating to the melting of ferrous solids
HUT43010A (en) Dispersions with increased sulfur content
GR3006357T3 (en)
EP0161187A3 (en) 17 beta-(substituted thio) androstenes
GB8624875D0 (en) 2 6-naphthalenedi-carboxylic acid
GB2154406B (en) Port for graphitization furnace
GR3007486T3 (en)
CS374486A2 (en) Furnace's arch
GB2178748B (en) Novel flameproofing agents
EP0243497A4 (en) Organotitanium compounds and surface-treating agents.
EP0197280A3 (en) Benzoyl ureas
EP0149977A3 (en) N-phosphoryl or n-thiophosphoryl-n'-s-triazinyl-formamidines